Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Drops A Point During Week. More details...
New Antibody Will Enter Phase II. More details...
CBT 200 Gives Up 7 Points. More details...
CBT 200 Moves 10 Points Higher. More details...
Hurricane Fears Force Prices Lower. More details...
CBT 200 Losses 80 Points. More details...
CBT 200 Drops 8.5 Points. More details...
Terms Are Improving. More details...
CBT 200 Gains 62 Points. More details...
An Additional $19 Million To Top Off The Year. More...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China